Moacyr Nobre
Universidade de São Paulo
H-index: 33
Latin America-Brazil
Top articles of Moacyr Nobre
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A Profile of Medical Students at the University of São Paulo. Is the Admissions Test Biased? | Revista Brasileira de Educação Médica | Joaquim Edson Vieira Moacyr Roberto Cucê Nobre Maria do Patrocínio Tenório Nunes Milton de Arruda Martins | 2021/6/28 |
O Perfil do Aluno da Faculdade de Medicina da Universidade de São Paulo. Vestibular Seleciona com Viés? | Revista Brasileira de Educação Médica | Joaquim Edson Vieira Moacyr Roberto Cucê Nobre Maria do Patrocínio Tenório Nunes Milton de Arruda Martins | 2021/6/28 |
Risk factors for adverse events of colorectal endoscopic submucosal dissection: a systematic review and meta-analysis | Juliana B Santos Moacyr RC Nobre Cleyton Z Oliveira Adriana V Safatle-Ribeiro Fabio Kawaguti | 2021/12/1 | |
Avaliação crítica de estudos de custo-efetividade de medicamentos oncológicos recomendados para incorporação pela Conitec no Brasil | J. bras. econ. saúde (Impr.) | Tatiane Bomfim Ribeiro Moacyr R Cuce Nobre Antônio Carlos Coelho Campino | 2020 |
Accelerated vs regular approval pathways: Differences in study characteristics in the approval of lung cancer treatments by the FDA from 2006 to 2018 | Tatiane Ribeiro Lewis Buss Sanni Ali Moacyr Nobre | 2020 | |
185 Bringing up leaders to multiply the promotion of healthy lifestyle among adolescents peers | BMJ Leader | Rachel Zanetta Moacyr Nobre Anna Carolina Alencar | 2020/11/1 |
Accelerated vs regular approval, differences in study characteristics of lung cancer treatments approved by the US Food and Drug Administration | Tatiane Ribeiro Lewis Buss Sanni Ali Moacyr Nobre | 2020 | |
Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018 | PLoS One | Tatiane Bomfim Ribeiro Lewis Buss Cole Wayant Moacyr Roberto Cuce Nobre | 2020/7/24 |
Iniciativas brasileiras de estudos de intervenção em andamento para a COVID-19 | Tatiane Bomfim Ribeiro Talita Aona Mazotti Moacyr R Cuce Nobre Airton Stein Daniela Oliveira de Melo | 2020 | |
New lung cancer treatments in Brazil, inequalities in patient access between the private and public health systems and differences in market access compared with the USA | Journal of Cancer Policy | Tatiane Bomfim Ribeiro Daniela Oliveira de Melo Silvana Márcia Bruschi Kelles Moacyr Roberto Cuce Nobre | 2020/6/1 |
US Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer | International Journal of Technology Assessment in Health Care | Tatiane Bomfim Ribeiro Adalton Ribeiro Luíza de Oliveira Rodrigues Guilherme Harada Moacyr Roberto Cuce Nobre | 2020/1 |
